Indications and uses
for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
take first dose one hour before starting activity adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor
Phenylketonurics: each tablet contains : phenylalanine 0.28 mg store at room temperature 15º - 30ºC (59º - 86ºF)
Meclizine Hydrochloride 25 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
for children under 12 years of age unless directed by a doctor
taking sedatives or tranquilizers
ask a doctor before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Aspartame, compressible sugar, croscarmellose sodium, dextrose, FD&C red 40 (al-lake), magnesium stearate, microcrystalline cellulose, raspberry flavor
Call toll free: 1-855-215-8180
Motion Sickness Relief
30 Tablets 15 Pouches (2 Tablets per Pouch)
NDC 51013-322-54
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51013-322-54 | Motion Sickness Relief | 15 in 1 CARTON | TABLET, CHEWABLE | 15 | 1 | |
| 51013-322-54 | Motion Sickness Relief | 2 in 1 POUCH | TABLET, CHEWABLE | 2 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51013-322 | 51013-322-54 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| RASPBERRY | 4N14V5R27W | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SUCROSE | C151H8M554 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Motion Sickness Relief | MECLIZINE HCL | PuraCap Pharmaceutical LLC | 8d772ff0-1476-48ca-a7e4-9473ce3db83a | 2017-11-28 | Warnings | 51013-322-54 51013-322 51013032254 116d1b6a-03af-4b3c-a81a-e1a598bf4f6b 8d772ff0-1476-48ca-a7e4-9473ce3db83a |
Adverse event summaries are temporarily unavailable. Other product information remains available.